Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

2.

Isolation, purification, structural analysis and biological activities of water-soluble polysaccharide from Glehniae radix.

Du B, Fu Y, Wang X, Jiang H, Lv Q, Du R, Yang Y, Rong R.

Int J Biol Macromol. 2019 May 1;128:724-731. doi: 10.1016/j.ijbiomac.2019.01.159. Epub 2019 Jan 28.

PMID:
30703419
3.

A Mechanism Underlying Attenuation of Recombinant Influenza A Viruses Carrying Reporter Genes.

Zhao X, Wang L, Cui Q, Li P, Wang Y, Zhang Y, Yang Y, Rong L, Du R.

Viruses. 2018 Nov 30;10(12). pii: E679. doi: 10.3390/v10120679.

4.

Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus.

Cui Q, Cheng H, Xiong R, Zhang G, Du R, Anantpadma M, Davey RA, Rong L.

Viruses. 2018 Nov 30;10(12). pii: E678. doi: 10.3390/v10120678.

5.

A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase.

Li P, Cui Q, Wang L, Zhao X, Zhang Y, Manicassamy B, Yang Y, Rong L, Du R.

Viruses. 2018 Jun 13;10(6). pii: E325. doi: 10.3390/v10060325.

6.

Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor.

Cui Q, Du R, Anantpadma M, Schafer A, Hou L, Tian J, Davey RA, Cheng H, Rong L.

Viruses. 2018 Mar 27;10(4). pii: E152. doi: 10.3390/v10040152.

7.

A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.

Du R, Wang L, Xu H, Wang Z, Zhang T, Wang M, Ning Y, Deng F, Hu Z, Wang H, Li Y.

Antiviral Res. 2017 Nov;147:131-141. doi: 10.1016/j.antiviral.2017.10.013. Epub 2017 Oct 20.

PMID:
29061442
8.

Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.

Schafer A, Cheng H, Lee C, Du R, Han J, Perez J, Peet N, Manicassamy B, Rong L.

Curr Med Chem. 2018;25(38):5177-5190. doi: 10.2174/0929867324666171010141416. Review.

PMID:
29032747
9.

[Generation of Japanese Encephalitis Virus-like Particle Vaccine and Preliminary Evaluation of Its Protective Efficiency].

Zhang Y, Du R, Huang S, Zhang T, Liu J, Zhu B, Wang H, Deng F, Cao S.

Bing Du Xue Bao. 2016 Mar;32(2):150-5. Chinese.

PMID:
27396157
10.

Characterization of the viral fibroblast growth factor homolog of Helicoverpa armigera single nucleopolyhedrovirus.

Yin F, Du R, Kuang W, Yang G, Wang H, Deng F, Hu Z, Wang M.

Virol Sin. 2016 Jun;31(3):240-8. doi: 10.1007/s12250-016-3710-z. Epub 2016 Apr 28.

PMID:
27142667
11.

An in vitro recombination-based reverse genetic system for rapid mutagenesis of structural genes of the Japanese encephalitis virus.

Du R, Wang M, Hu Z, Wang H, Deng F.

Virol Sin. 2015 Oct;30(5):354-62. doi: 10.1007/s12250-015-3623-2. Epub 2015 Sep 30.

PMID:
26463213
12.

Resistant mutations and quasispecies complexity of hepatitis B virus during telbivudine treatment.

Yin F, Wu Z, Fang W, Wu C, Rayner S, Han M, Deng F, Du R, Liu J, Wang M, Wang H, Ning Q, Hu Z.

J Gen Virol. 2015 Nov;96(11):3302-12. doi: 10.1099/jgv.0.000285. Epub 2015 Sep 16.

PMID:
26382925
13.

Glycoprotein E of the Japanese encephalitis virus forms virus-like particles and induces syncytia when expressed by a baculovirus.

Du R, Yin F, Wang M, Hu Z, Wang H, Deng F.

J Gen Virol. 2015 May;96(Pt 5):1006-14. doi: 10.1099/vir.0.000052. Epub 2015 Jan 15.

PMID:
25593161

Supplemental Content

Loading ...
Support Center